SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-011631
Filing Date
2023-04-28
Accepted
2023-04-28 16:16:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A pirs20230408_defa14a.htm DEFA14A 8071
2 nanda_page1.jpg GRAPHIC 183163
3 nanda_page2.jpg GRAPHIC 135571
  Complete submission text file 0001437749-23-011631.txt   448187
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37471 | Film No.: 23866445
SIC: 2834 Pharmaceutical Preparations